Guili Lian

865 total citations
38 papers, 577 citations indexed

About

Guili Lian is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Guili Lian has authored 38 papers receiving a total of 577 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 16 papers in Molecular Biology and 12 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Guili Lian's work include Pulmonary Hypertension Research and Treatments (18 papers), MicroRNA in disease regulation (6 papers) and Cardiovascular Function and Risk Factors (5 papers). Guili Lian is often cited by papers focused on Pulmonary Hypertension Research and Treatments (18 papers), MicroRNA in disease regulation (6 papers) and Cardiovascular Function and Risk Factors (5 papers). Guili Lian collaborates with scholars based in China and United States. Guili Lian's co-authors include Liangdi Xie, Li Luo, Huajun Wang, Tingjun Wang, Changsheng Xu, Jin Gong, Ai Chen, Guonan Chen, Guoyan Xu and Ying Zhang and has published in prestigious journals such as Journal of the American College of Cardiology, PLoS ONE and Scientific Reports.

In The Last Decade

Guili Lian

34 papers receiving 574 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guili Lian China 16 278 193 133 96 56 38 577
Bowen Li China 14 226 0.8× 140 0.7× 80 0.6× 119 1.2× 28 0.5× 46 556
Hirotaka Yamamoto Japan 14 199 0.7× 180 0.9× 133 1.0× 80 0.8× 16 0.3× 50 663
Przemysław Leszek Poland 13 292 1.1× 66 0.3× 335 2.5× 86 0.9× 31 0.6× 82 800
Tomohiro Suhara Japan 9 334 1.2× 306 1.6× 59 0.4× 239 2.5× 69 1.2× 14 655
Yuhu He China 11 147 0.5× 112 0.6× 50 0.4× 59 0.6× 42 0.8× 16 425
Qi Huang China 15 263 0.9× 124 0.6× 71 0.5× 96 1.0× 27 0.5× 41 664
Ku-Geng Huo Canada 8 169 0.6× 54 0.3× 85 0.6× 71 0.7× 88 1.6× 13 425
Shumei Zhong Canada 15 247 0.9× 199 1.0× 194 1.5× 98 1.0× 17 0.3× 29 785
Xianjin Bi China 15 268 1.0× 71 0.4× 40 0.3× 57 0.6× 56 1.0× 18 649

Countries citing papers authored by Guili Lian

Since Specialization
Citations

This map shows the geographic impact of Guili Lian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guili Lian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guili Lian more than expected).

Fields of papers citing papers by Guili Lian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guili Lian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guili Lian. The network helps show where Guili Lian may publish in the future.

Co-authorship network of co-authors of Guili Lian

This figure shows the co-authorship network connecting the top 25 collaborators of Guili Lian. A scholar is included among the top collaborators of Guili Lian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guili Lian. Guili Lian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Xing, Xiaojun Chen, Weibin Wu, et al.. (2025). Zinc Alleviates Diabetic Muscle Atrophy via Modulation of the SIRT1/FoxO1 Autophagy Pathway Through GPR39. Journal of Cachexia Sarcopenia and Muscle. 16(2). e13771–e13771. 3 indexed citations
2.
Chen, Ai, et al.. (2025). Hypoxia-induced histone lactylation promotes pulmonary arterial smooth muscle cells proliferation in pulmonary hypertension. Molecular and Cellular Biochemistry. 480(11). 5685–5697. 1 indexed citations
3.
Chen, Ai, Yan Yan, Weijun Lin, et al.. (2025). Role of insulin signaling dysregulation in pulmonary vascular remodeling in rats with monocrotaline-induced pulmonary arterial hypertension. Frontiers in Cardiovascular Medicine. 12. 1543319–1543319.
4.
Chen, Ai, et al.. (2024). Zinc attenuates monocrotaline-induced pulmonary hypertension in rats through upregulation of A20. Journal of Molecular and Cellular Cardiology. 195. 24–35. 1 indexed citations
5.
6.
Chen, Hongyin, Yun Dong, Yunyun Su, et al.. (2024). Integrative omics analysis identifies biomarkers of septic cardiomyopathy. PLoS ONE. 19(11). e0310412–e0310412.
7.
Cai, Kexin, et al.. (2024). Transcriptomics changes of calcitonin gene-related peptide in mitigating lipopolysaccharide-induced septic cardiomyopathy. Scientific Reports. 14(1). 26385–26385. 1 indexed citations
8.
Chen, Ai, Jin Gong, Weijun Lin, et al.. (2023). Comprehensive analyses of m6A RNA methylation patterns and related immune microenvironment in idiopathic pulmonary arterial hypertension. Frontiers in Genetics. 14. 1222368–1222368. 9 indexed citations
9.
Cai, Kexin, Xiaojun Chen, Jing Wang, et al.. (2023). Exploring potential therapeutic agents for lipopolysaccharide-induced septic cardiomyopathy based on transcriptomics using bioinformatics. Scientific Reports. 13(1). 20589–20589. 7 indexed citations
11.
Wu, Xiaoting, Liyan Yang, Yi Chen, et al.. (2022). Reduced Neutrophil Extracellular Trap Formation During Ischemia Reperfusion Injury in C3 KO Mice: C3 Requirement for NETs Release. Frontiers in Immunology. 13. 781273–781273. 30 indexed citations
13.
Lian, Guili, Tingjun Wang, Ai Chen, et al.. (2022). The zinc transporter ZIP12 regulates monocrotaline-induced proliferation and migration of pulmonary arterial smooth muscle cells via the AKT/ERK signaling pathways. BMC Pulmonary Medicine. 22(1). 111–111. 20 indexed citations
14.
Lian, Guili, et al.. (2021). Zinc-mediated activation of CREB pathway in proliferation of pulmonary artery smooth muscle cells in pulmonary hypertension. Cell Communication and Signaling. 19(1). 103–103. 17 indexed citations
15.
Wang, Tingjun, et al.. (2020). Transcriptomic analysis identifies Toll‐like and Nod‐like pathways and necroptosis in pulmonary arterial hypertension. Journal of Cellular and Molecular Medicine. 24(19). 11409–11421. 42 indexed citations
16.
Lian, Guili, et al.. (2020). Role of 20-hydroxyeicosatetraenoic acid in pulmonary hypertension and proliferation of pulmonary arterial smooth muscle cells. Pulmonary Pharmacology & Therapeutics. 64. 101948–101948. 8 indexed citations
17.
Wang, Tingjun, et al.. (2019). Low-Grade Albuminuria Is Associated with Left Ventricular Hypertrophy and Diastolic Dysfunction in Patients with Hypertension. Kidney & Blood Pressure Research. 44(4). 590–603. 23 indexed citations
18.
Wang, Tingjun, et al.. (2018). Development of a Rat Model of Sick Sinus Syndrome Using Pinpoint Press Permeation. BioMed Research International. 2018. 1–7. 2 indexed citations
19.
Lian, Guili, et al.. (2018). CPT1 regulates the proliferation of pulmonary artery smooth muscle cells through the AMPK-p53-p21 pathway in pulmonary arterial hypertension. Molecular and Cellular Biochemistry. 455(1-2). 169–183. 46 indexed citations
20.
Lian, Guili, et al.. (2015). GW26-e1796 Effect of Ruanmailing containing serum on twinfilin-1 in PDGF-activated vascular smooth muscle cells. Journal of the American College of Cardiology. 66(16). C45–C45. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026